REQUEST A DEMO
Total
USD $0.00
Search more companies

Fiterman Pharma SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fiterman Pharma SRL Profile Updated: September 16, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Romanian Download a sample report

The company was established in Iasi, in 1995, as the first drug producer under full Romanian ownership from Moldavia, under the name of MARK PHARMACEUTICS SRL. In 2008 the company's name changed to Fiterman Pharma SRL.
From the modest beginning of a small production laboratory of drugs, with only four employees, in 14 years the company includes over 100 employees and about 50 products in portfolio.

Headquarters
Strada Moara De Foc Nr. 35
IASI; Iasi; Postal Code: 700520

Contact Details: Purchase the Fiterman Pharma SRL report to view the information.

Website: http://www.fitermanpharma.ro

Basic Information
Total Employees:
Purchase the Fiterman Pharma SRL report to view the information.
Registered Capital:
Purchase the Fiterman Pharma SRL report to view the information.
Incorporation Date:
December 07, 1994
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
43.6393%
Purchase this report to view the information.
27.9344%
Purchase this report to view the information.
13.8033%
Purchase this report to view the information.
13.8033%
Purchase this report to view the information.
0.4918%
Subsidiaries
Fiterman Distribution SRL
80%
Arcadia Hospital SRL
40%
Fiterman Retail SRL
20%
Company Performance
Financial values in the chart are available after Fiterman Pharma SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-7.79%
Total operating revenue
-7.77%
Operating profit (EBIT)
-77.07%
EBITDA
-58.01%
Net Profit (Loss) for the Period
-43.92%
Total assets
1.7%
Total equity
-1.43%
Operating Profit Margin (ROS)
-6.45%
Net Profit Margin
-3.51%
Return on Equity (ROE)
-2.92%
Quick Ratio
-0.42%
Cash Ratio
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?